These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6176354)
1. A controlled study of maintenance chemoimmunotherapy vs immunotherapy alone immediately following palliative gastrectomy and induction chemoimmunotherapy for advanced gastric cancer. Tokai cooperative study group for adjuvant chemoimmunotherapy of stomach cancer. Yasue M; Murakami M; Nakazato H; Suchi T; Ota K Cancer Chemother Pharmacol; 1981; 7(1):5-10. PubMed ID: 6176354 [TBL] [Abstract][Full Text] [Related]
2. [A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: the fourth study]. Yamamura Y; Yasue M; Nakazato H; Ota K Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):541-8. PubMed ID: 3923941 [TBL] [Abstract][Full Text] [Related]
3. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer]. Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293 [TBL] [Abstract][Full Text] [Related]
4. Immunochemosurgery as a new approach to reasonable treatment of advanced cancer. Kim JP Ann Acad Med Singap; 1988 Jan; 17(1):48-54. PubMed ID: 3056221 [TBL] [Abstract][Full Text] [Related]
5. [Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer]. Yamamura Y; Yasue M; Kito T; Nakazato H; Yamada E Gan To Kagaku Ryoho; 1983 Jul; 10(7):1603-9. PubMed ID: 6409009 [TBL] [Abstract][Full Text] [Related]
6. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy]. Sakata Y; Yoshida Y; Komatsu Y; Sugawara K; Nishimura S; Kikuchi K Gan To Kagaku Ryoho; 1982 Jan; 9(1):109-15. PubMed ID: 6820875 [TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of immunochemotheray on advanced gastric cancer--combination of OK-432 (picibanil), mitomycin C, and 5-fluorouracil (MF-O therapy) (author's transl)]. Nio Y; Nakamoto K; Tanaka A; Kikuchi S; Henmi K Nihon Gan Chiryo Gakkai Shi; 1980 Apr; 15(2):161-5. PubMed ID: 7400644 [No Abstract] [Full Text] [Related]
8. Treatment of gastric cancer, with special reference to the survivals of the cancer patients treated with multiple combination MFC therapy or immunochemotherapy of MFC plus OK-432 (NSC B116209). Suga S; Tsunekawa H; Washino M; Makino N; Tamura Z; Goto S Gastroenterol Jpn; 1977; 12(2):20-9. PubMed ID: 892332 [TBL] [Abstract][Full Text] [Related]
9. Immunochemosurgery for gastric cancer. Kim JP Semin Surg Oncol; 1985; 1(3):105-15. PubMed ID: 4059752 [TBL] [Abstract][Full Text] [Related]
10. [Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer]. Sugiyama Y; Yoshida A; Takao H; Kunieda K; Miya K; Azuma S; Tanemura H; Furuta T; Saji S Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1592-5. PubMed ID: 2117890 [TBL] [Abstract][Full Text] [Related]
11. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Kim JP; Kwon OJ; Oh ST; Yang HK Ann Surg; 1992 Sep; 216(3):269-78; discussion 278-9. PubMed ID: 1417176 [TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer. Cocconi G; DeLisi V; Di Blasio B Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233 [TBL] [Abstract][Full Text] [Related]
13. [A case with gastric cancer by OK-MF'C therapy (author's transl)]. Tomomatsu H; Morita N; Nagai T; Shiwaku Y; Shingami T; Miura Y; Kihara K; Nakao Y; Shimokawahara H; Hashimoto S; Yunoki K Igaku Kenkyu; 1979 Sep; 49(3):268-76. PubMed ID: 547643 [No Abstract] [Full Text] [Related]
14. [Adjuvant chemotherapy in patients with radical resection of stomach cancer: 5-year results of a prospective randomized study]. Jakesz R; Dittrich C; Funovics J; Hofbauer F; Rainer H; Reiner G; Schemper M; Schiessel R; Starlinger M Wien Klin Wochenschr; 1986 Dec; 98(24):824-30. PubMed ID: 3103336 [TBL] [Abstract][Full Text] [Related]
15. [Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer]. Imaizumi M; Kondo T; Kamei H; Ichihashi H Gan To Kagaku Ryoho; 1984 Jan; 11(1):60-8. PubMed ID: 6421243 [TBL] [Abstract][Full Text] [Related]
16. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer]. Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682 [TBL] [Abstract][Full Text] [Related]
17. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)]. Tamada R; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Abe O; Kikuchi K; Tanabe T; Nakajima T Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):716-22. PubMed ID: 3103540 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of endoscopic injections of OK-432 in the treatment of gastric cancer. Nakazawa S; Yoshino J; Okamura S; Yamao K Scand J Gastroenterol; 1988 Jun; 23(5):539-45. PubMed ID: 3041555 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemoimmunotherapy for gastric carcinoma. Makowka L; Falk RE; Ambus U; Bugala R; Landi S Can J Surg; 1980 Sep; 23(5):429-31. PubMed ID: 6159957 [TBL] [Abstract][Full Text] [Related]
20. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results]. Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]